
Laboratory for bioinspired protein drugs and technologies
We work on the behavior of proteins, to understand mechanisms and to utilize them as tools to develop therapies and technologies. One focus is to understand disease-associated protein aggregation, and to find ways to counteract this process using natural molecular chaperones and engineered proteins. We also study mechanisms to enable therapeutics to cross the blood-brain barrier. Furthermore, we study proteins from spider silk to create biotechnological tools and novel biomaterials.

Janne Johansson
Our research aims to develop novel therapeutics based on detailed studies of protein structures and mechanisms of action.

Axel Abelein
Our research aims to understand the underlying mechanisms of amyloid formation to both find treatment strategies against dementia diseases, in particular Alzheimer’s and Parkinson’s disease.

Gefei Chen
Our main research interests centre around the understanding of how molecular chaperones interfere with different types of protein aggregation and alleviate relevant toxicities for developing novel treatments, in particular against cancer and neurodegenerative diseases.

Anna Rising
Our research is mainly focused on using spider silk technology for various medical applications.